Equillium, Inc.
For the period ended Dec 31, 2025. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 25, 2026
EQ$1.50-0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share and par value data)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $30,277 | $18,085 |
| Short-term investments | - | 4,490 |
| Prepaid expenses and other current assets | 761 | 2,403 |
| Total current assets | 31,038 | 24,978 |
| Operating lease right-of-use assets | 658 | 364 |
| Property and equipment, net | 164 | 262 |
| Other assets | 27 | - |
| Total assets | $31,887 | $25,604 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $755 | $2,676 |
| Accrued expenses | 1,816 | 3,483 |
| Current portion of operating lease liabilities | 363 | 197 |
| Total current liabilities | 2,934 | 6,356 |
| Long-term operating lease liabilities | 356 | 187 |
| Total liabilities | 3,290 | 6,543 |
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2025 and 2024; 61,464,368 and 35,557,563 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 5 | 3 |
| Additional paid-in capital | 244,434 | 212,084 |
| Accumulated other comprehensive income | 363 | 781 |
| Accumulated deficit | (216,205) | (193,807) |
| Total stockholders' equity | 28,597 | 19,061 |
| Total liabilities and stockholders' equity | $31,887 | $25,604 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.